Burney Co. cut its holdings in Humana Inc (NYSE:HUM) by 2.2% in the 1st quarter, HoldingsChannel reports. The fund owned 3,797 shares of the insurance provider’s stock after selling 84 shares during the period. Burney Co.’s holdings in Humana were worth $1,010,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in HUM. Proficio Capital Partners LLC lifted its stake in Humana by 81.4% in the fourth quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 48 shares during the last quarter. Destination Wealth Management lifted its stake in Humana by 130.0% in the first quarter. Destination Wealth Management now owns 115 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 65 shares during the last quarter. Sontag Advisory LLC purchased a new position in Humana in the fourth quarter valued at approximately $47,000. Zions Bancorporation N.A. purchased a new position in Humana in the first quarter valued at approximately $51,000. Finally, Athena Capital Advisors LLC purchased a new position in Humana in the fourth quarter valued at approximately $57,000. 92.63% of the stock is owned by institutional investors.
HUM has been the topic of several recent research reports. Oppenheimer dropped their target price on Humana from $373.00 to $350.00 and set an “outperform” rating on the stock in a research report on Thursday, May 2nd. Credit Suisse Group dropped their target price on Humana from $352.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, May 2nd. Citigroup dropped their target price on Humana from $362.00 to $302.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. SunTrust Banks dropped their target price on Humana to $300.00 in a research report on Thursday, May 2nd. Finally, UBS Group initiated coverage on Humana in a research report on Tuesday, April 23rd. They set a “neutral” rating and a $266.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the company’s stock. Humana presently has an average rating of “Buy” and a consensus target price of $337.26.
Shares of HUM stock opened at $246.08 on Thursday. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.40. Humana Inc has a 52-week low of $225.65 and a 52-week high of $355.88. The firm has a market capitalization of $32.84 billion, a P/E ratio of 16.91, a price-to-earnings-growth ratio of 1.01 and a beta of 0.85.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.30 by $0.18. Humana had a return on equity of 20.77% and a net margin of 2.99%. The company had revenue of $16.11 billion for the quarter, compared to the consensus estimate of $15.67 billion. During the same quarter last year, the business posted $3.36 earnings per share. The firm’s revenue was up 12.8% compared to the same quarter last year. On average, analysts predict that Humana Inc will post 17.44 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.55 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.89%. Humana’s dividend payout ratio (DPR) is presently 15.12%.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2019/06/13/humana-inc-nysehum-stake-lessened-by-burney-co.html.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also: What is the Gross Domestic Product (GDP)?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.